SCHEMBL7615520

SCHEMBL7615520

[CH2]CCC[CH]C(=O)Nc1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
MAPT P10636 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 1/20 0.51
RAB9A P51151 9/20 0.49
NPC1 O15118 8/20 0.49
KDM4E B2RXH2 3/20 0.49
CYP1A2 P05177 2/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP2C19 P33261 1/20 0.49
HIF1A Q16665 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.47
EPHX1 P07099 2/20 0.45
HDAC1 Q13547 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31162428 0.77 FYN (0.62) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL1380888 0.77 FYN (0.62) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL4156245 0.76 CES1 (0.44) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL7607582 0.74 KDM4E (0.51) MEN1KMT2AMAPTPOLBRAB9A
SCHEMBL13717187 0.74 PTPN11 (0.43) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL15309134 0.73 RAB9A (0.59) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL1176632 0.71 RAB9A (0.65) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL13381356 0.71 LPAR2 (0.67) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL21515098 0.71 LPAR2 (0.67) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL11586886 0.71 LPAR2 (0.67) MEN1KMT2AMAPTL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020198254-A1 Polyamide analogs GENELABS TECHNOLOGIES, INC. 2002-12-26 US claimed
WO-2002062755-A2 POLYAMIDE ANALOGS AS DNA MINOR GROOVE BINDERS GENELABS TECHNOLOGIES, INC. (US) 2002-08-15 WO claimed
US-20020198254-A1 Polyamide analogs GENELABS TECHNOLOGIES, INC. 2002-12-26 US disclosed
WO-2002062755-A2 POLYAMIDE ANALOGS AS DNA MINOR GROOVE BINDERS GENELABS TECHNOLOGIES, INC. (US) 2002-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198254-A1 Polyamide analogs CYP51A1, HDAC6, ERG28 MEN1 2087/4885KMT2A 2871/4885MAPT 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.